China OKs Heterologous Booster Shots Amid Heated COVID Vaccine Race

Major Commercial Opportunity Opens Up

 
• By Dexter Jie Yan

CanSino and Zhifei have received the regulatory green light for their respective COVID-19 booster shots in China and an estimated $1.3bn vaccine market is now up for grabs. Domestic contenders are set to elbow each other in the sector with a range of viral vector, recombinant protein and mRNA-based jabs.

mRNA COVID-19 vaccine
Estimated $1.3bn new market in China up for grabs by COVID-19 vaccine makers • Source: Alamy

More from China

More from Focus On Asia